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LETTER TO THE EDITOR
Severe hypoxemia follows
hypoxic pulmonary
ﬂow  rate  of  6  L/min.  Subsequently,  sevoﬂurane  concentra-
tions  were  reduced  to  5%  within  the  ﬁrst  minute  and  to  2%
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anesthetics: prognostic
potential of 100% shunt
fractions
Hipoxemia grave após VPH e/ou inibic¸ão da
VPH por anestésicos inalatórios: potencial
prognóstico de frac¸ões de shunt de 100%
Dear  Editor:
Hypoxic  Pulmonary  Vasoconstriction  (HPV)  was  ﬁrst  reported
by  Bindsley  et  al.  in  adult  patients  and  was  managed  using
double  lumen  catheters  to  ventilate  one  lung  with  100%
oxygen  and  the  other  with  95%  N2 and  5%  oxygen  during
intravenous  barbiturate  and  fentanyl  anesthesia.1 However,
‘‘HPV  inhibition’’  has  predominantly  been  attributed  to
the  use  of  inhalation  agents  and  is  considered  as  a  cause
of  hypoxia  during  anesthesia.  Moreover,  both  in  vitro  and
in  vivo  studies  have  demonstrated  that  inhalation  agents
inhibit  HPV  under  a  range  of  conditions,2--5 and  sevoﬂu-
rane  has  been  shown  to  decrease  HPV  in  a  dose-dependent
manner.4,6,7
Case description
Here  we  report  a  case  of  severe  hypoxemia  during  sevoﬂu-
rane  induction  in  a  6  year-old  boy  who  was  scheduled  for
adenotonsillectomy.  The  patient  was  treated  according  to
American  Society  of  Anesthesiology  (ASA)  class  I  and  weighed
22  kg.  Pre-operative  assessments,  physical  examinations,
and  laboratory  investigations  were  unremarkable,  and  the
patient  had  a  hemoglobin  level  of  12  mg/dL  and  a  hemat-
ocrit  of  36%.  Following  transfer  to  the  operating  room  withPlease  cite  this  article  in  press  as:  Oksar  M,  et  al.  Severe  hypo
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no  pre-medication,  routine  Electrocardiography  (ECG),  non-
invasive  blood  pressure,  and  SpO2 levels  were  monitored.
Anesthesia  was  introduced  via  a  facemask  and  a  pediatric
circle  system  providing  8%  sevoﬂurane  in  100%  oxygen  at  a
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ion,  rocuronium  (0.6  mg/kg)  was  administered,  and  SpO2
evels  rapidly  and  progressively  decreased  from  98%  to  38%
t  10  and  15  min  of  induction,  respectively,  with  no  clini-
al  explanation.  As  a  consequence,  the  patients’  Heart  Rate
HR)  suddenly  decreased  from  109  to  90  bpm  in  response  to
ypoxia,  and  sevoﬂurane  concentrations  were  reduced  to  2%
nd  subsequently  discontinued  prior  to  tracheal  intubation
nd  ventilation  with  100%  oxygen.  Efﬁcient  lung  ventilation
as  possible  throughout  the  period.  A  clinical  improvement
as  observed  within  seconds  of  intubation  and  ventilation,
nd  SpO2 levels  and  HR  returned  to  100%  and  118  bpm,
espectively.  No  blood  pressure  abnormalities  were  observed
uring  the  procedure,  and  the  rapid  restoration  of  SpO2
nd  HR  with  100%  oxygen  was  considered  symptomatic  of
n  adverse  drug  reaction.  Thus,  anesthesia  was  maintained
ith  1%--1.5%  sevoﬂurane  and  oxygen  in  50%  N2O.
iscussion
PV  is  considered  as  a  protective  mechanism  that  opti-
izes  systemic  oxygen  delivery.  Thus,  the  inhibition  of  HPV
y  inhalational  agents  is  believed  to  cause  hypoxia  during
nesthesia.  However,  the  protective  effects  of  HPV  against
ypoxia  may  depend  on  the  size  of  affected  lung  regions.
ung  tissues  are  globally  affected  by  all  pulmonary  anesthet-
cs,  and  sevoﬂurane  has  been  shown  to  induce  pulmonary
essel  dilatation  in  normoxia.7 Therefore,  HPV  should  be
onsidered  as  a  multifactorial  response  to  local  or  global
ulmonary  hypoxia  during  acute  hypoxia.  Thus,  the  present
bservations  suggest  that  the  degree  of  acute  local  shunting
an  be  used  to  determine  whether  HPV  mechanism  is  use-
ul  or  not.  The  type  of  anesthetics  can  be  signiﬁcant  with
egard  to  this  reaction.
It  is  widely  accepted  that  inhalation  agents  have  global
ffects  on  pulmonary  vessels  during  either  induction  or
aintenance  of  anesthesia.  Thus,  hypoxemia  because  of
lobal  HPV  is  likely  in  the  presence  of  100%  intrapulmonaryxemia  follows  hypoxic  pulmonary  vasoconstriction  and/or
thetics:  prognostic  potential  of  100%  shunt  fractions.  Rev
.02.003
hunt  fractions,  and  the  protective  effects  of  HPV-inﬂuenced
erfusion  to  the  better  ventilated  lung  regions  to  improve
xygenation  may  be  abolished  under  these  conditions.  In
ontrast,  inhibition  of  HPV  by  inhalation  agents  in  commonly
Elsevier Editora Ltda. This is an open access article under the CC
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ffected  lungs  leads  to  rapid  onset  of  hypoxemia  because
f  normal  effects  on  perfusion  and  alveolar  hypoxia  and
irect  effects  of  anesthesia.  Thus,  the  effect  of  HPV  inhi-
ition  by  inhalation  agents  or  hypoxia  may  depend  on  global
ffects  on  lungs  and  the  ensuing  shunt  fractions.  Therefore,
e  suggest  that  both  HPV  and  HPV  inhibition  may  cause
ypoxemia  under  certain  conditions.  However,  the  relation-
hip  between  pulmonary  anesthetic  administration  and  HPV
emains  controversial.
In conclusion,  global  effects  of  inhalation  induction  with
evoﬂurane  at  high  concentrations  may  cause  oxygen  desat-
ration  in  lungs  that  are  normally  ventilated  with  100%
xygen,  potentially  resulting  in  global  inhibition  of  HPV.
owever,  these  conditions  may  be  a  consequence  of  global
PV  and  associated  100%  shunt  fractions.  Thus,  despite
he  high  level  evidence  of  no  differences  in  outcomes  fol-
owing  pulmonary  and  intravenous  anesthesia,  the  hypoxic
onsequences  of  inhalation  anesthesia  require  further  clar-
ﬁcation.
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s  available  for  review  by  the  Editor  of  this  journal.Please  cite  this  article  in  press  as:  Oksar  M,  et  al.  Severe  hypo
hypoxic  pulmonary  vasoconstriction  inhibition  by  inhaled  anes
Bras  Anestesiol.  2016.  http://dx.doi.org/10.1016/j.bjane.2016
onﬂicts interest
he  authors  declare  no  conﬂicts  of  interest.
K
∗
E PRESS
LETTER  TO  THE  EDITOR
eferences
. Bindslev L, Jolin A, Hedenstierna G, et al. Hypoxic pulmonary
vasoconstriction in the human lung: effect of repeated hypoxic
challenges during anesthesia. Anesthesiology. 1985;62:621--5.
. Marshall C, Lindgren L, Marshall BE. Effects of halothane, enﬂu-
rane, and isoﬂurane on hypoxic pulmonary vasoconstriction in rat
lungs in vitro. Anesthesiology. 1984;60:304--8.
. Domino KB, Borowec L, Alexander CM, et al. Inﬂuence of
isoﬂurane on hypoxic pulmonary vasoconstriction in dogs. Anes-
thesiology. 1986;64:423--9.
. Ishibe Y, Gui X, Uno H, et al. Effect of sevoﬂurane on hypoxic
pulmonary vasoconstriction in the perfused rabbit lung. Anes-
thesiology. 1993;79:1348--53.
. Loer SA, Scheeren TW, Tarnow J. Desﬂurane inhibits hypoxic pul-
monary vasoconstriction in isolated rabbit lungs. Anesthesiology.
1995;83:552--6.
. Kerbaul F, Bellezza M, Guidon C, et al. Effects of sevoﬂurane on
hypoxic pulmonary vasoconstriction in anaesthetized piglets. Br
J Anaesth. 2000;85:440--5.
. Liu R, Ueda M, Okazaki N, et al. Role of potassium channels
in isoﬂurane- and sevoﬂurane-induced attenuation of hypoxic
pulmonary vasoconstriction in isolated perfused rabbit lungs.
Anesthesiology. 2001;95:939--46.
enekse  Oksar ∗,  Onur  Koyuncu,  Selim  Turhanoglu
Department  of  Anesthesiology  and  Reanimation,  Mustafaxemia  follows  hypoxic  pulmonary  vasoconstriction  and/or
thetics:  prognostic  potential  of  100%  shunt  fractions.  Rev
.02.003
emal  University  Faculty  of  Medicine,  Hatay,  Turkey
Corresponding  author.
-mail:  menekseoksar@gmail.com  (M.  Oksar).
